Predictive 5-Year Survivorship Model of Cystic Fibrosis

TLDR

The study aimed to develop a 5‑year survivorship model to pinpoint key clinical predictors in cystic fibrosis. Using longitudinal data from the Cystic Fibrosis Foundation Patient Registry, the authors built and validated multivariate logistic regression models on 5,820 of 11,630 patients. The validated model incorporated age, FEV1% predicted, gender, weight‑for‑age z‑score, pancreatic sufficiency, diabetes, Staphylococcus aureus, Burkholderia cepacia, and annual exacerbations, offering a rigorous tool for clinical practice and research.

Abstract

The objective of this study was to create a 5-year survivorship model to identify key clinical features of cystic fibrosis. Such a model could help researchers and clinicians to evaluate therapies, improve the design of prospective studies, monitor practice patterns, counsel individual patients, and determine the best candidates for lung transplantation. The authors used information from the Cystic Fibrosis Foundation Patient Registry (CFFPR), which has collected longitudinal data on approximately 90% of cystic fibrosis patients diagnosed in the United States since 1986. They developed multivariate logistic regression models by using data on 5,820 patients randomly selected from 11,630 in the CFFPR in 1993. Models were tested for goodness of fit and were validated for the remaining 5,810 patients for 1993. The validated 5-year survivorship model included age, forced expiratory volume in 1 second as a percentage of predicted normal, gender, weight-for-age z score, pancreatic sufficiency, diabetes mellitus, Staphylococcus aureus infection, Burkerholderia cepacia infection, and annual number of acute pulmonary exacerbations. The model provides insights into the complex nature of cystic fibrosis and supplies a rigorous tool for clinical practice and research.